Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Safety Profile and What to Expect Therapeutic peptides demonstrate favorable safety profiles across preclinical and observational human data
The reduced IGFBP affinity results in a dramatically extended half-life compared to native IGF-1, making IGF-1 LR3 valuable for laboratory research involving: Extended IGF-1 receptor activation studies Prolonged growth factor signaling pathway research IGFBP interaction and modulation studies Comparative studies with native IGF-1 For Canadian researchers studying growth factor pathways, IGF-1 LR3 provides a tool for understanding sustained receptor activation without the rapid clearance seen with native IGF-1
Factors influencing progress include: Starting Weight: Higher starting weights may result in more rapid initial losses
Obesity treatment uses 2.4mg weekly maintenance (Wegovy equivalent)
US$ 29.83
US$ 29.57
US$ 23.04
US$ 24.35
US$ 20.43
US$ 24.48
US$ 22.69
US$ 27.68
